KIT and leukemia: In addition, the antitumor effect of PF was evaluated using a panel of cell lines, including a mutant KIT-expressing leukemia cell line (Kasumi), wild type KIT-expressing cell lines (Colo320DM and H128), and KIT-negative cell lines (HeLa, Capan-1, and MDA-MB-231).